How much funding has Reprieve Cardiovascular raised?

Reprieve Cardiovascular has raised $103.0M in total funding, most recently a Series B round.

When was Reprieve Cardiovascular founded?

Reprieve Cardiovascular was founded in 2018.

Where is Reprieve Cardiovascular headquartered?

Reprieve Cardiovascular is headquartered in Milford, Massachusetts, United States.

What industry is Reprieve Cardiovascular in?

Reprieve Cardiovascular operates in Healthcare, Medical Devices.

How many employees does Reprieve Cardiovascular have?

Reprieve Cardiovascular has 11-50 employees.

Reprieve Cardiovascular

Q: Who are Reprieve Cardiovascular's investors?

Reprieve Cardiovascular's investors include Deerfield Management, Lightstone Ventures, Sante Ventures, Arboretum Ventures.

Bringing intelligence to decongestion management for heart failure patients

Milford, United States · Founded 2018 · $103.0M raised

Healthcare

Medical Devices

Headquarters: Milford, Massachusetts
Employees: 11–50
Founded: 2018
Business Model: B2B

Website: reprievecardio.com
Total Funding: $103.0M
Last Round: $61.0M Series BAug 2025
Rounds: 2

About

Reprieve Cardiovascular is a pioneering medical device company focused on automated fluid management technologies for patients with acute decompensated heart failure (ADHF). The company's Reprieve System combines real-time diuretic response measurement, semi-automated IV diuretic titration, and precise fluid removal monitoring to give physicians full visibility and control throughout decongestion therapy. By replacing the 60-year-old standard-of-care diuretic approach with an intelligent, data-driven alternative, Reprieve aims to safely accelerate fluid removal, reduce average hospital stays, and improve outcomes for the 8.5 million heart failure patients hospitalized annually in the United States.

Summary

Reprieve Cardiovascular is a Healthcare company based in Milford, United States, founded in 2018. It has raised $103.0M in total across 2 rounds, most recently a $61.0M Series B round in Aug 2025. Investors include Deerfield Management, Lightstone Ventures and Sante Ventures.